Floatz logo

Therapeutic Asset Ratings

436 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
YH-003 (HUMANIZED AGONISTIC ANTI-CD40 IGG2 MONOCLONAL ANTIBODY)
Advanced Solid Tumors
Eucure (Beijing) Biopharma Co., LtdP1/2CCC (52)
Binimetinib
Advanced Solid Tumors
Roswell Park Cancer InstituteP2CCC (51)
su011248
Advanced Solid Tumors
Canadian Cancer Trials GroupP2CCC (51)
RIFALDAZINE
Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.P1CCC (51)
Belzutifan
Advanced Solid Tumors
Merck Sharp & Dohme LLCP2CCC (50)
Calderasib
Advanced Solid Tumors
Merck Sharp & Dohme LLCP2CCC (50)
Losartan
Advanced Solid Tumors
Ain Shams UniversityP2CCC (50)
mk-1084
Advanced Solid Tumors
Merck Sharp & Dohme LLCP2CCC (50)
RITONAVIR
Advanced Solid Tumors
DualityBio Inc.P2CCC (50)
Shr-A1811
Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.P2CCC (50)
Sotorasib
Advanced Solid Tumors
AmgenP2CCC (50)
Spartalizumab
Advanced Solid Tumors
University Hospital, BordeauxP2CCC (50)
Tucatinib
Advanced Solid Tumors
OnKure, Inc.P2CCC (50)
AZD1775
Advanced Solid Tumors
AstraZenecaP2CCC (48)
Dasatinib
Advanced Solid Tumors
Canadian Cancer Trials GroupP2CCC (48)
Lopinavir
Advanced Solid Tumors
DualityBio Inc.P2CCC (48)
Risovalisib
Advanced Solid Tumors
Haihe Biopharma Co., Ltd.P2CCC (48)
Surufatinib
Advanced Solid Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyP2CCC (48)
VEMURAFENIB
Advanced Solid Tumors
Seoul National University Bundang HospitalP2CCC (48)
2x-121
Advanced Solid Tumors
Allarity TherapeuticsP1/2CCC (48)
Anti-EGFR Antibody-drug Conjugate MRG003
Advanced Solid Tumors
Shanghai Miracogen Inc.P1/2CCC (48)
Capecitabine
Advanced Solid Tumors
BOE Technology Group Co., Ltd.P1/2CCC (48)
Darolutamide
Advanced Solid Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP1/2CCC (48)
Ivonescimab
Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP1/2CCC (48)
Shr-A2009
Advanced Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.P1/2CCC (48)
Showing 51 to 75 of 436 assets
PreviousPage 3 of 18Next